GSK1120212
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
GSK1120212 inhibits MEK1/2 and is currently in clinical trials as a potential treatment for... more
Product information "GSK1120212"
GSK1120212 inhibits MEK1/2 and is currently in clinical trials as a potential treatment for melanoma. GSK1120212 exhibits anticancer chemotherapeutic activity, upregulating p27 expression and inhibiting growth in colorectal cancer cells and suppressing tumor growth in colorectal cancer xenografts.
| Keywords: | Trametinib, JTP-74057 |
| Supplier: | LKT Laboratories |
| Supplier-Nr: | G7440 |
Properties
| Application: | MEK1/2 inhibitor |
| MW: | 615.39 D |
| Purity: | >98% |
| Format: | Solid |
Database Information
| CAS : | 871700-17-3| Matching products |
| KEGG ID : | K04369 | Matching products |
Handling & Safety
| Storage: | +20°C |
| Shipping: | +20°C (International: +20°C) |
| Signal Word: | Danger |
| GHS Hazard Pictograms: |
|
| H Phrases: | H317, H361, H372 |
| P Phrases: | P201, P202, P260, P261, P264, P270, P272, P280, P281, P302+P352, P308+P313, P314, P333+P313, P363, P405, P501 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed